Clinical Trial Update: Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ezetimibe/simvastatin (10/40 mg) versus doubling the atorvastatin dose in high-risk patients with hypercholesterolemia; the study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• atorvastatin (atorvastatin)
• ezetimibe/simvastatin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2011-10-31